Obstructive sleep apnea and vitamin D deficiency are closely linked
Bookmark1. In this systematic review and meta-analysis, patients with obstructive sleep apnea...
Read MoreSep 27, 2023
Bookmark1. In this systematic review and meta-analysis, patients with obstructive sleep apnea...
Read MoreSep 27, 2023
Bookmark1. This phase 2 randomized clinical trial found that patients with metastatic colorectal...
Read MoreSep 22, 2023
Bookmark1. In this prospective cohort study, middle-aged nurses with an evening chronotype were...
Read MoreSep 22, 2023
Bookmark1. Disease-free survival at 24 months was 84% in the nivolumab group compared to 73% in...
Read MoreSep 22, 2023
Bookmark1. Patients with non-erosive gastro-esophageal reflux disease (GERD) do not have an...
Read MoreSep 21, 2023
Bookmark1. In this randomized controlled trial, treatment with pegozafermin improved fibrosis in...
Read MoreSep 21, 2023
Bookmark1. Monthly migraine days were significantly reduced in atogepant 30 mg twice daily and...
Read MoreSep 21, 2023
Bookmark1. Patients with a new diagnosis of osteoporotic vertebral compression fracture (OVCF) are...
Read MoreSep 20, 2023
1. In this cross-sectional study, the proportion of Chinese adults with self-reported type 2...
Read MoreSep 20, 2023
Bookmark1. HbA1c reduction was dose-dependent in the semaglutide group with the greatest change...
Read MoreSep 20, 2023
Bookmark1. Following total knee replacement (TKR) for osteoarthritis, patients randomized to a...
Read MoreSep 19, 2023
Bookmark1. 37% of study patients had an objective response to treatment with atezolizumab. 2....
Read MoreSep 19, 2023
Bookmark1. The objective response rate was 29.8% (1% complete response, 66% partial response) with...
Read MoreSep 19, 2023
Bookmark1. In this cohort study, using generic versus brand-name fluticasone-salmeterol was...
Read MoreSep 19, 2023
Bookmark1. Despite the decrease in colonoscopies performed at the start of the COVID-19 pandemic,...
Read MoreSep 16, 2023
Bookmark1. In this randomized controlled trial, adjunctive treatment with escitalopram or...
Read MoreSep 16, 2023
Bookmark1. The semaglutide 50 mg group saw a 15.1% reduction in body weight at 68 weeks compared...
Read MoreSep 15, 2023
Bookmark1. In this randomized controlled trial, the triple-hormone-receptor agonist retatrutide...
Read MoreSep 15, 2023
Bookmark1. In this randomized controlled trial, the elective NaV1.8 inhibitor VX-548 reduced acute...
Read MoreSep 15, 2023
Bookmark1. Time to disease flare was significantly shorter in the placebo group versus...
Read More